Unusual carbon build-up found in lungs of COPD patients As a result, cells grow abnormally large and cause inflammation Date: June 10, 2025 Source: European Respiratory Society Summary: Scientists ...

For COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher, MD, MHS, of Duke University in Durham, North Carolina.

The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday. Labeling for the interleukin-5 (IL ...

The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

“Using the new COPD diagnostic schema, compared with individuals classified as not having COPD, those with a new diagnosis of COPD had greater all-cause and respiratory-specific mortality, more ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of life in patients with eosinophilic chronic obstructive pulmonary disease ...

Smoking can't explain why women are more at risk for COPD, a new study says.

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung tissue.

New research reveals how COPD impacts women uniquely, urging tailored approaches for diagnosis and treatment.

A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options.

By COPD Action Alliance The COPD Action Alliance is an advocacy coalition that helps to increase awareness, support grassroots advocacy and improve COPD policy.

If you’ve been diagnosed with chronic obstructive pulmonary disease, or COPD, you probably have shortness of breath during physical exertion. Regular exercise may seem intimidating, but it’s ...